What is a stock summary page? Click here for an overview.
Business Description
Harvard Apparatus Regenerative Technology Inc
NAICS : 325412
SIC : 2834
ISIN : US09074M2026
Description
Harvard Apparatus Regenerative Technology Inc is a clinical-stage biotechnology company developing regenerative-medicine treatments for disorders of the gastrointestinal system and the airway resulting from cancer, trauma, or birth defects. The company's technology is based on its proprietary cell-therapy platform that uses a patient's own stem cells to regenerate and restore function to damaged organs.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.46 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -21.44 | |||||
| Beneish M-Score | 9.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 15.1 | |||||
| 3-Year EPS without NRI Growth Rate | 14.5 | |||||
| 3-Year FCF Growth Rate | -7.9 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 16.96 | |||||
| 9-Day RSI | 21.97 | |||||
| 14-Day RSI | 25.35 | |||||
| 3-1 Month Momentum % | -6.14 | |||||
| 6-1 Month Momentum % | -52.11 | |||||
| 12-1 Month Momentum % | -17.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.17 | |||||
| Quick Ratio | 3.09 | |||||
| Cash Ratio | 2.43 | |||||
| Days Inventory | 93.82 | |||||
| Days Sales Outstanding | 51.57 | |||||
| Days Payable | 823.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -13.9 | |||||
| Shareholder Yield % | -22.28 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.21 | |||||
| Operating Margin % | -1796.74 | |||||
| Net Margin % | -1798.14 | |||||
| FCF Margin % | -1128.37 | |||||
| ROE % | -449.9 | |||||
| ROA % | -234.13 | |||||
| ROIC % | -429.13 | |||||
| 3-Year ROIIC % | 81.69 | |||||
| ROC (Joel Greenblatt) % | -4634.94 | |||||
| ROCE % | -425.36 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 68.57 | |||||
| PB Ratio | 9 | |||||
| Price-to-Tangible-Book | 9 | |||||
| EV-to-EBIT | -3.69 | |||||
| EV-to-EBITDA | -3.77 | |||||
| EV-to-Revenue | 65.98 | |||||
| EV-to-FCF | -5.85 | |||||
| Price-to-Net-Current-Asset-Value | 13.85 | |||||
| Price-to-Net-Cash | 22.5 | |||||
| Earnings Yield (Greenblatt) % | -27.1 | |||||
| FCF Yield % | -16.93 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HRGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Harvard Apparatus Regenerative Technology Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.43 | ||
| EPS (TTM) ($) | -0.53 | ||
| Beta | -0.28 | ||
| 3-Year Sharpe Ratio | 0.04 | ||
| 3-Year Sortino Ratio | 0.06 | ||
| Volatility % | 111.16 | ||
| 14-Day RSI | 25.35 | ||
| 14-Day ATR ($) | 0.065498 | ||
| 20-Day SMA ($) | 2.1512 | ||
| 12-1 Month Momentum % | -17.74 | ||
| 52-Week Range ($) | 1.8 - 5.9 | ||
| Shares Outstanding (Mil) | 15.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Harvard Apparatus Regenerative Technology Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Harvard Apparatus Regenerative Technology Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Harvard Apparatus Regenerative Technology Inc Frequently Asked Questions
What is Harvard Apparatus Regenerative Technology Inc(HRGN)'s stock price today?
The current price of HRGN is $1.80. The 52 week high of HRGN is $5.90 and 52 week low is $1.80.
When is next earnings date of Harvard Apparatus Regenerative Technology Inc(HRGN)?
The next earnings date of Harvard Apparatus Regenerative Technology Inc(HRGN) is 2025-04-04 Est..
Does Harvard Apparatus Regenerative Technology Inc(HRGN) pay dividends? If so, how much?
Harvard Apparatus Regenerative Technology Inc(HRGN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers